Enasidenib-Induced Differentiation Syndrome in IDH2-Mutant Acute Myeloid Leukemia
JAMA Oncol
.
2018 Aug 1;4(8):1110-1111.
doi: 10.1001/jamaoncol.2017.4724.
Author
Shyam A Patel
1
Affiliation
1
Department of Medicine, Divisions of Hematology and Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
PMID:
29346477
DOI:
10.1001/jamaoncol.2017.4724
No abstract available
Publication types
Comment
MeSH terms
Aminopyridines
Humans
Isocitrate Dehydrogenase*
Leukemia, Myeloid, Acute*
Triazines
Substances
Aminopyridines
Triazines
enasidenib
Isocitrate Dehydrogenase